[1]
2025. Anti-Angiogenesis of Theaflavin-Derived Copper Oxide: Comparative Analysis of In Vitro and In Vivo Models. Journal of Carcinogenesis. 24, 6s (Sep. 2025), 209–221. DOI:https://doi.org/10.64149/J.Carcinog.24.6s.209-221.